Correlation Between Altamira Therapeutics and Pyxis Oncology
Can any of the company-specific risk be diversified away by investing in both Altamira Therapeutics and Pyxis Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Altamira Therapeutics and Pyxis Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Altamira Therapeutics and Pyxis Oncology, you can compare the effects of market volatilities on Altamira Therapeutics and Pyxis Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Altamira Therapeutics with a short position of Pyxis Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Altamira Therapeutics and Pyxis Oncology.
Diversification Opportunities for Altamira Therapeutics and Pyxis Oncology
-0.12 | Correlation Coefficient |
Good diversification
The 3 months correlation between Altamira and Pyxis is -0.12. Overlapping area represents the amount of risk that can be diversified away by holding Altamira Therapeutics and Pyxis Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pyxis Oncology and Altamira Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Altamira Therapeutics are associated (or correlated) with Pyxis Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pyxis Oncology has no effect on the direction of Altamira Therapeutics i.e., Altamira Therapeutics and Pyxis Oncology go up and down completely randomly.
Pair Corralation between Altamira Therapeutics and Pyxis Oncology
Given the investment horizon of 90 days Altamira Therapeutics is expected to generate 0.42 times more return on investment than Pyxis Oncology. However, Altamira Therapeutics is 2.37 times less risky than Pyxis Oncology. It trades about -0.11 of its potential returns per unit of risk. Pyxis Oncology is currently generating about -0.23 per unit of risk. If you would invest 49.00 in Altamira Therapeutics on August 28, 2024 and sell it today you would lose (6.00) from holding Altamira Therapeutics or give up 12.24% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Altamira Therapeutics vs. Pyxis Oncology
Performance |
| Timeline |
| Altamira Therapeutics |
| Pyxis Oncology |
Altamira Therapeutics and Pyxis Oncology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Altamira Therapeutics and Pyxis Oncology
The main advantage of trading using opposite Altamira Therapeutics and Pyxis Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Altamira Therapeutics position performs unexpectedly, Pyxis Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pyxis Oncology will offset losses from the drop in Pyxis Oncology's long position.| Altamira Therapeutics vs. Eliem Therapeutics | Altamira Therapeutics vs. HCW Biologics | Altamira Therapeutics vs. Scpharmaceuticals | Altamira Therapeutics vs. Milestone Pharmaceuticals |
| Pyxis Oncology vs. Zura Bio Limited | Pyxis Oncology vs. Altamira Therapeutics | Pyxis Oncology vs. Elevation Oncology | Pyxis Oncology vs. Mereo BioPharma Group |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Complementary Tools
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |